| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |